Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pathologic Complete Response”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07829081
What this trial is testing

Research on Effective Strategies After Immunotherapy for Mismatch Repair-deficient Early-stage GI Tumors

Who this might be right for
Quality of Life (QOL)Mismatch Repair Deficient Colorectal CancerMicrosatellite Instability-High Colorectal Cancer+8 more
University Hospital, Basel, Switzerland 234
Post-approval studies (Phase 4)UnknownNCT04603794
What this trial is testing

Efficacy of Mouthwash in Reducing Salivary Carriage of COVID-19

Who this might be right for
COVID-19
Ohio State University 60
Large-scale testing (Phase 3)Looking for participantsNCT06431633
What this trial is testing

Study of Treatment With Sacituzumab and Zimberelimab for Patients With Lung Cancer Confined to the Chest and Previously Operated on Who Were Not Disease-free.

Who this might be right for
Lung DiseasesCarcinoma, Non-Small-Cell LungResectable Lung Non-Small Cell Carcinoma
Fundación GECP 129
Testing effectiveness (Phase 2)UnknownNCT01630226
What this trial is testing

Cisplatin-monotherapy in the Treatment of BRCA1 Positive Breast Cancer Patients in Poland

Who this might be right for
BRCA1 MutationBreast Cancer Invasive Nos
Pomeranian Medical University Szczecin 100
Large-scale testing (Phase 3)Active Not RecruitingNCT05629585
What this trial is testing

Dato-DXd With or Without Durvalumab Versus Investigator's Choice of Therapy in Patients With Stage I-III Triple-negative Breast Cancer Without Pathological Complete Response Following Neoadjuvant Therapy (TROPION-Breast03)

Who this might be right for
Breast Cancer
AstraZeneca 1,174
Not applicableUnknownNCT05050890
What this trial is testing

Prognostic Value of Circulating Tumor DNA Dosing in Patients in Neoadjuvant Breast Neoplasia

Who this might be right for
Breast Neoplasm
Instituto Brasileiro de Controle do Cancer 38
Testing effectiveness (Phase 2)Study completedNCT02458014
What this trial is testing

Blinatumomab in Treating Patients With B-cell Acute Lymphoblastic Leukemia With Minimal Residual Disease

Who this might be right for
Adult Acute Lymphoblastic Leukemia in Complete RemissionB Acute Lymphoblastic LeukemiaMinimal Residual Disease+1 more
M.D. Anderson Cancer Center 37
Testing effectiveness (Phase 2)Study completedNCT01401959
What this trial is testing

Trial of Eribulin in Patients Who Do Not Achieve Pathologic Complete Response (pCR) Following Neoadjuvant Chemotherapy

Who this might be right for
Metastatic Breast Cancer
SCRI Development Innovations, LLC 127
Not applicableLooking for participantsNCT06299202
What this trial is testing

Contrast-enhanced Spectral Mammography (CESM) Early Quantitative Evaluation of Tumoral Response and Pathologic Complete Response Prediction for Localized Breast Cancer Treated by Neoadjuvant Chemotherapy

Who this might be right for
Breast Cancer
Hospices Civils de Lyon 100
Early research (Phase 1)Looking for participantsNCT06245746
What this trial is testing

UCMSC-Exo for Chemotherapy-induced Myelosuppression in Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid LeukemiaNeutropeniaAnemia+3 more
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 9
Not applicableStudy completedNCT01490853
What this trial is testing

Follow-up of Ph+ Chronic Myleoid Leukemia Patients in Complete Cytogenetic Response With Interferon Based Therapy

Who this might be right for
Chronic Myeloid Leukemia
Università degli Studi di Brescia 116
Not applicableLooking for participantsNCT07327970
What this trial is testing

Prospective Validation of Ataraxis AI Test for Predicting Treatment Response in Neoadjuvant Breast Cancer

Who this might be right for
Breast Cancer
Young-Joon Kang 150
Not applicableStudy completedNCT02575612
What this trial is testing

Diagnosis of Pathological Complete Response by Minimal Invasive Biopsy After Neoadjuvant Chemotherapy in Breast Cancer

Who this might be right for
Breast Neoplasms
Heidelberg University 50
Not applicableUnknownNCT05925751
What this trial is testing

Deep Learning Signature for Predicting Complete Pathological Response to Neoadjuvant Chemoimmunotherapy in Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung CancerNeoadjuvant ChemoimmunotherapyComplete Pathological Response
Shanghai Pulmonary Hospital, Shanghai, China 100
Testing effectiveness (Phase 2)Looking for participantsNCT06802757
What this trial is testing

Posaconazole Plus PD-1 Inhibitors and Chemotherapy vs PD-1 Inhibitors and Chemotherapy in Neoadjuvant Therapy for Triple Negative Breast Cancer

Who this might be right for
Breast Cancer
Shandong Cancer Hospital and Institute 72
Not applicableStudy completedNCT01430663
What this trial is testing

Diagnosing Pulmonary Aspergillosis in Patients With Hematological Malignancies: A Multicentre Prospective Evaluation of an Aspergillus PCR Assay and a Galactomannan ELISA in Bronchoalveolar Lavage Samples

Who this might be right for
Invasive Aspergillosis
Heidelberg University 87
Large-scale testing (Phase 3)Looking for participantsNCT05812807
What this trial is testing

Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab

Who this might be right for
Anatomic Stage II Breast Cancer AJCC v8Early Stage Triple-Negative Breast CarcinomaAnatomic Stage IIIA Breast Cancer AJCC v8+1 more
Alliance for Clinical Trials in Oncology 1,295
Not applicableStudy completedNCT06595758
What this trial is testing

This Study Investigates the Impact of Single Nucleotide Polymorphisms in Genes Involved in the Pharmacokinetics and Toxicity of Doxorubicin (DOX) in Egyptian Female Patients with Breast Cancer. It Also Aims to Explore the Association of Pretreatment Neutrophil to Lymphocyte Ratio to PCR

Who this might be right for
Breast Cancer
Menoufia University 100
Not applicableUnknownNCT03548844
What this trial is testing

Local Excision Versus Total Mesorectal Excision In Pathological Complete Response (ypT0-1cN0) Mid- Or Low-Rectal Cancer After Neoadjuvant Therapy

Who this might be right for
Rectal CancerSurgery
Yanhong Deng 326
Testing effectiveness (Phase 2)UnknownNCT05160285
What this trial is testing

Neoadjuvant Nivolumab for Upper Tract Urothelial Carcinoma

Who this might be right for
Upper Urinary Tract Urothelial Carcinoma
YULISU 29
Next Page